NasdaqGM - Nasdaq Real Time Price USD

Septerna, Inc. (SEPN)

9.06
-0.36
(-3.82%)
At close: May 21 at 4:00:00 PM EDT
8.96
-0.10
(-1.10%)
Pre-Market: 8:51:51 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
977
1,075
151
0
Operating Expense
92,220
81,898
45,701
27,967
Operating Income
-91,243
-80,823
-45,550
-27,967
Net Non Operating Interest Income Expense
11,800
8,617
2,786
291
Other Income Expense
-70
-90
47,635
--
Pretax Income
-79,513
-72,296
4,871
-27,676
Tax Provision
-405
-498
691
0
Net Income Common Stockholders
-79,108
-71,798
567
-27,676
Average Dilution Earnings
--
--
62
--
Diluted NI Available to Com Stockholders
-79,108
-71,798
629
-27,676
Basic EPS
-1.78
-7.26
0.03
-1.42
Diluted EPS
-1.78
-7.26
0.03
-1.42
Basic Average Shares
44,448.44
9,891.13
19,495.76
19,495.76
Diluted Average Shares
44,448.44
9,891.13
19,495.76
19,495.76
Total Operating Income as Reported
-91,243
-80,823
2,075
-27,967
Total Expenses
92,220
81,898
45,701
27,967
Net Income from Continuing & Discontinued Operation
-79,108
-71,798
4,180
-27,676
Normalized Income
-79,108
-71,798
-36,682.25
-27,676
Interest Income
11,800
8,617
2,786
291
Net Interest Income
11,800
8,617
2,786
291
EBIT
-91,243
-80,823
-45,550
-27,967
EBITDA
-89,761
-79,422
-44,702
-27,390
Reconciled Depreciation
1,482
1,401
848
577
Net Income from Continuing Operation Net Minority Interest
-79,108
-71,798
4,180
-27,676
Total Unusual Items Excluding Goodwill
0
0
47,625
0
Total Unusual Items
0
0
47,625
0
Normalized EBITDA
-89,761
-79,422
-92,327
-27,390
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
6,762.75
0
12/31/2022 - 10/25/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NRXS NeurAxis, Inc.
3.2000
-19.80%
 
EYEN Eyenovia, Inc.
1.4000
-16.17%
 
BCLI Brainstorm Cell Therapeutics Inc.
1.1800
-4.84%
 
INZY Inozyme Pharma, Inc.
3.9500
0.00%
 
AFMD Affimed N.V.
0.1815
0.00%
 
CABA Cabaletta Bio, Inc.
1.7950
-4.52%
 
ABP Abpro Corporation
0.2546
-0.12%
 
AKRO Akero Therapeutics, Inc.
48.35
+1.64%
 
ACAD ACADIA Pharmaceuticals Inc.
21.85
+0.74%
 
PTIX Protagenic Therapeutics, Inc.
6.14
-10.76%